Cargando…

Role of Maternal Antibodies in Infants with Severe Diseases Related to Human Parechovirus Type 3

Human parechovirus type 3 (HPeV3) is an emerging pathogen that causes sepsis and meningoencephalitis in young infants. To test the hypothesis that maternal antibodies can protect this population, we measured neutralizing antibody titers (NATs) to HPeV3 and other genotypes (HPeV1 and HPeV6) in 175 co...

Descripción completa

Detalles Bibliográficos
Autores principales:	Aizawa, Yuta, Watanabe, Kanako, Oishi, Tomohiro, Hirano, Harunobu, Hasegawa, Isao, Saitoh, Akihiko
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Centers for Disease Control and Prevention 2015
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4622238/ https://www.ncbi.nlm.nih.gov/pubmed/26485714 http://dx.doi.org/10.3201/eid2111.150267

Ejemplares similares

993 Role of Maternal Antibodies in Human Parechovirus Type 3 Infection in Young Infants
por: Aizawa, Yuta, et al.
Publicado: (2014)

Asymptomatic Adults and Children Can Transmit Human Parechoviruses and Enteroviruses to Neonates and Young Infants
por: Izumita, Ryohei, et al.
Publicado: (2017)

994 Human Parechovirus Type 3 Infection as a Cause of Apnea in Premature Infants
por: Nirei, Jun, et al.
Publicado: (2014)

Can We Distinguish between Human Parechovirus Type 3 and Enteroviruses Infection in Neonates and Young Infants Based on their Clinical and Laboratory Findings?
por: Izumita, Ryohei, et al.
Publicado: (2017)

2586. Human Breast Milk Inhibits the Replication of Parechovirus-A3
por: Izumita, Ryohei, et al.
Publicado: (2019)

2585. Changing Epidemiological Profile of Infantile Parechovirus-A3 Infection in Japan
por: Aizawa, Yuta, et al.
Publicado: (2019)

Antiviral Activity of Peptide Nucleic Acid against Human Parechovirus Type 3
por: O tsuka, Taketo, et al.
Publicado: (2017)

2853. Innate Immune Response in Serum and Cerebrospinal Fluid of Neonates and Infants Infected with Parechovirus-A3 and Enteroviruses
por: Habuka, Rie, et al.
Publicado: (2019)

2349. Long-Term Neurological Outcome and Neutralizing Antibody Titers Against Paraechovirus-A3 (PeV-A3) in Children who Developed PeV-A3-Related Diseases in Neonatal and Infantile Periods
por: Izumita, Ryohei, et al.
Publicado: (2018)

Parechovirus infections in infants
por: Paquette, Maude, et al.
Publicado: (2023)

Myeloid-associated differentiation marker is an essential host factor for human parechovirus PeV-A3 entry
por: Watanabe, Kanako, et al.
Publicado: (2023)

Infant identical triplets’ presentation of human parechovirus Type 3
por: Weichelt, Bryan, et al.
Publicado: (2019)

Isolation and Characterization of Novel Human Parechovirus from Clinical Samples
por: Watanabe, Kanako, et al.
Publicado: (2007)

Parechovirus and enteroviruses among young infants with sepsis in Iran
por: Makvandi, Manoochehr, et al.
Publicado: (2021)

1328. Human Parechovirus in Infants: A Case Series
por: Robles, Tiffany, et al.
Publicado: (2023)

The particulars on parechovirus
por: Shah, Gauri, et al.
Publicado: (2014)

Human Parechovirus 1, 3 and 4 Neutralizing Antibodies in Dutch Mothers and Infants and Their Role in Protection Against Disease
por: Karelehto, Eveliina, et al.
Publicado: (2018)

Development of Monoclonal Antibodies and Antigen-Capture ELISA for Human Parechovirus Type 3
por: Goto, Keiko, et al.
Publicado: (2020)

2635. Outbreak of Enterovirus D68 Among Children in Japan and Simultaneous Circulation of Clade B3 in Europe
por: Ikuse, Tatsuki, et al.
Publicado: (2019)

An Emerging Human Parechovirus Type 5 Causing Sepsis-Like Illness in Infants in Australia
por: Chamings, Anthony, et al.
Publicado: (2019)

An outbreak of severe infections among Australian infants caused by a novel recombinant strain of human parechovirus type 3
por: Nelson, Tiffanie M., et al.
Publicado: (2017)

Genomic Characterization of Novel Human Parechovirus Type
por: Li, Linlin, et al.
Publicado: (2009)

Severe human parechovirus sepsis beyond the neonatal period
por: Sainato, Rebecca, et al.
Publicado: (2011)

Human parechovirus meningoencephalitis
por: Suthar, Pokhraj P., et al.
Publicado: (2023)

Genome Sequence of Novel Human Parechovirus Type 17
por: Böttcher, Sindy, et al.
Publicado: (2017)

Human Parechovirus Central Nervous System Infection in a Young Infant Cohort
por: Katragkou, Aspasia, et al.
Publicado: (2023)

Fourth Human Parechovirus Serotype
por: Benschop, Kimberley S.M., et al.
Publicado: (2006)

Human Parechovirus Infections in Canada
por: Abed, Yacine, et al.
Publicado: (2006)

Human Parechovirus Infection, Denmark
por: Fischer, Thea K., et al.
Publicado: (2014)

Replication and Inhibitors of Enteroviruses and Parechoviruses
por: van der Linden, Lonneke, et al.
Publicado: (2015)

Epidemic Myalgia Associated with Human Parechovirus Type 3 Infection
por: Miyazaki, Moemi, et al.
Publicado: (2019)

Cerebral imaging and neurodevelopmental outcome after entero- and human parechovirus sepsis in young infants
por: de Jong, Eveline P., et al.
Publicado: (2017)

Seroepidemiology of Parechovirus A3 Neutralizing Antibodies, Australia, the Netherlands, and United States
por: Karelehto, Eveliina, et al.
Publicado: (2019)

Severe Generalized Epidemic Myalgia in an Adult due to Human Parechovirus Type 3: A Case Report
por: Masuda, Sakue, et al.
Publicado: (2022)

Rooting human parechovirus evolution in time
por: Faria, Nuno R, et al.
Publicado: (2009)

Novel Human Parechovirus from Brazil
por: Drexler, Jan Felix, et al.
Publicado: (2009)

Novel Human Parechovirus, Sri Lanka
por: Pham, Ngan Thi Kim, et al.
Publicado: (2010)

Human Parechovirus 3 and Neonatal Infections
por: Boivin, Guy, et al.
Publicado: (2005)

Myocarditis Caused by Human Parechovirus in Adult
por: Kong, Khai Lin, et al.
Publicado: (2017)

EP03 Parechovirus in a pathologist
por: Masih, Claire, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ric8o05mp0h7qf35dqgt4pste1